James Mulay
Director · 4 filings · Latest: Jun 15, 2026
CG Oncology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CGON | JAMES MULAY | — | Jul 1, 2026 | Proposed Sale | $71.05 | 3,928 | $279.1K | — | |
CGON | James Mulay | Director | Jun 15, 2026 | Sale | $60.12 | 1,964 | $118.1K | 0 | |
CGON | James Mulay | Director | Jun 15, 2026 | Option Exercise | $9.64 | 1,964 | $18.9K | 1,310 | |
CGON | James Mulay | Director | Apr 17, 2026 | Sale | $73.01 | 15,600 | $1.1M | 0 | |
CGON | James Mulay | Director | Apr 17, 2026 | Option Exercise | $36.63 | 15,600 | $571.4K | 15,600 | |
CGON | JAMES MULE | — | Apr 17, 2026 | Proposed Sale | $66.34 | 17,564 | $1.2M | — | |
CGON | James Mulay | Director | Mar 16, 2026 | Sale | $63.50 | 1,964 | $124.7K | 0 | |
CGON | James Mulay | Director | Mar 16, 2026 | Option Exercise | $9.64 | 1,964 | $18.9K | 1,310 | |
CGON | JAMES MULAY | — | Jan 9, 2026 | Proposed Sale | $41.93 | 13,109 | $549.7K | — | |
CGON | JAMES MULAY | — | Oct 9, 2025 | Proposed Sale | $40.71 | 6,557 | $266.9K | — | |
CGON | JAMES MULAY | — | Sep 18, 2025 | Proposed Sale | $37.72 | 35,441 | $1.3M | — | |
CGON | JAMES MULAY | — | Sep 5, 2025 | Proposed Sale | $30.94 | 27,015 | $835.8K | — |